Zobrazeno 1 - 10
of 352
pro vyhledávání: '"I, Barillot"'
Publikováno v:
Cancer/Radiothérapie. 27:225-232
Autor:
M. Delannes, P. Pommier, Didier Peiffert, L. Thomas, S. Renard, C. Charra-Brunaud, K. Peignaux, A.A. Serre, A. Ducassou, Delphine Antoni, I. Barillot, I. Menoux, A. Petit, Julia Salleron, D. Thibouw
Publikováno v:
Cancer/Radiothérapie. 26:474-480
Resume Objectifs de l’etude Nous presentons les resultats du PHRC Tridicol, etude prospective francaise de phase II dont l’objectif etait d’augmenter la dose delivree au volume cible lors de la curietherapie des cancers du col de l’uterus loc
Autor:
P, Giraud, C, Chargari, P, Maingon, J-M, Hannoun-Lévi, D, Azria, É, Monpetit, M-A, Mahé, I, Barillot, A, Lisbona, J-J, Mazeron
Publikováno v:
Cancer/Radiothérapie. 26:2-6
The purpose of the first two editions of the guidelines for external radiotherapy procedures, published in 2007 and 2016 respectively, was to issue recommendations aimed at optimising, harmonising and standardising practices. The purpose of this thir
Publikováno v:
Cancer/Radiothérapie. 26:7-13
The purpose of this article is to describe the regulatory framework of the radiotherapy practice in France.
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 26(1-2)
The purpose of this article is to describe the external irradiation process and updated recommendations of the French society for radiation oncology for patient follow-up.
Autor:
C, Charra-Brunaud, J, Salleron, I, Menoux, K, Peignaux, A, Ducassou, A, Petit, P, Pommier, I, Barillot, A A, Serre, L, Thomas, M, Delannes, D, Thibouw, D, Antoni, S, Renard, D, Peiffert
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 26(3)
We present the results of the PHRC Tridicol, a prospective French phase II study whose objective was to increase the dose delivered to the target volume during brachytherapy for locally advanced cervical cancers.Eight centers included 48 patients, tr
Publikováno v:
Cancer/Radiothérapie. 20:622-628
Intensity-modulated radiotherapy (IMRT) is increasingly used in order to minimize the gastrointestinal, genitourinary, and hematological toxicity in cervical and uterine cancers. However, the benefit of this high-precision approach is detracted by th
Publikováno v:
Cancer/Radiothérapie. 20:530-534
Treatment with monoclonal antibodies, especially rituximab, is more and more frequent and questions the interest of radiotherapy in limited stages of diffuse B-cell large cell and follicular non-Hodgkin's lymphomas. From a review of literature, it ap
Autor:
I. Barillot
Publikováno v:
Cancer/Radiothérapie. 21:557-559
The cooperation between radiation oncologists and physicists is essential to guarantee the quality and safety of the irradiation of our patients. It would be wrong to consider that the intervention of physicists in the patient management process is l
Autor:
I, Barillot, D, Antoni, J, Bellec, J, Biau, P, Giraud, C, Jenny, T, Lacornerie, A, Lisbona, V, Marchesi, F, Mornex, S, Supiot, S, Thureau, G, Noel
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 22(6-7)
Since decades, stereotactic radiotherapy has spread out worldwide. Published results are very numerous. To clarify obviousness among all the publications, this recommendation review was written. Voluntarily, authors limited analysis of international